Cyclopentanecarboximidamide hydrochloride

Catalog No.: 
ACRAON924
CAS No.: 
68284-02-6
Molecular Formula: 
C6H13ClN2
Molecular Weight: 
148.64
Cyclopentanecarboximidamide hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$136.00InquiryInquiry
1g95%$311.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameCyclopentanecarboximidamide hydrochloride
IUPAC Namecyclopentanecarboximidamide hydrochloride
MDL No.MFCD08752286
Molecular FormulaC6H13ClN2
Molecular Weight148.64
SMILESN=C(C1CCCC1)N.[H]Cl
InChI KeyIWYMAMAHNKEYNI-UHFFFAOYSA-N
SynonymCyclopentanecarboximidamide Hydrochloride(WX619914)
CAS No.68284-02-6
PubChem CID42614157

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACRAON924 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  2. Plus
  3. ACMXPY094 route compound structure diagram
    ACMXPY0944254-02-8In Stock
  4. Then
  5. ACRAON924 route product structure diagram
    ACRAON92468284-02-6
Inquiry

2. ACRAON924 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMXPY094 route compound structure diagram
    ACMXPY0944254-02-8In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACRAON924 route product structure diagram
    ACRAON92468284-02-6
Inquiry

3. ACRAON924 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRAON924 route product structure diagram
    ACRAON92468284-02-6
Inquiry

Comments (0)